KRAS and neoplasm: Gender, tumor location, metastatic organs, and KRAS status were not significantly associated with PFS, which was inconsistent with the result of REGONIVO study that all patients responding in the REGONIVO study (6) were male with lung metastases and had PS scores of 0.